Pulmonary Embolism International THrOmbolysis Study-3

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
In this study, we will assess the efficacy and safety of a reduced dose of thrombolytic therapy given in addition to low-molecular-weight heparin in patients with intermediate-high-risk acute pulmonary embolism. Half of participants will receive thrombolytic treatment, while the other half will receive a placebo.
Epistemonikos ID: 728f5e09beb7e398cb138405a73333bed9c01ab0
First added on: May 07, 2024